See the DrugPatentWatch profile for Tisotumab
How much does tisotumab vedotin cost (list price vs. what patients pay)?
The exact cost of tisotumab vedotin depends on the country, the specific product price set by payers/governments, and the patient’s insurance coverage (or out-of-pocket coverage). The provided information does not include pricing or reimbursement details, so I can’t give a verified number here.
If you tell me your country (and whether you mean list price, insurance copay, or estimated monthly cost), I can narrow the answer to the right context.
What drives the cost of tisotumab vedotin?
Pricing and patient cost usually vary based on:
- Dosing schedule and treatment cycles (drug spend depends on how many vials are needed per cycle)
- Insurance coverage and negotiated pricing (pharmacy benefit manager contracts)
- Whether it’s bought through a hospital/infusion center vs. a specialty pharmacy channel
- Patient-specific factors like deductible status, coinsurance, and any manufacturer support programs (if available in your region)
Is there a cheaper alternative (other drugs or biosimilars)?
Lower-cost options depend on your cancer type/line of therapy and local coverage rules. Whether a lower-cost alternative exists requires matching clinical context and local formulary status.
If you share your indication (or cancer type), line of therapy, and location, I can help map likely alternatives and the typical coverage questions patients ask.
How to get the most accurate price for your situation
To get a precise cost number, look for:
- The drug’s published list price in your country (if available)
- Your insurer’s drug benefit lookup (copay/coinsurance after deductible)
- The billing estimate from the infusion center (includes drug + administration and supply costs)
- Any manufacturer patient assistance or copay support in your region
If you share your country and whether you need “price per vial,” “monthly cost,” or “expected patient out-of-pocket,” I’ll tailor the estimate format to what’s usually reported there.
Sources
No pricing sources were provided in the prompt.